Carl Haslam

1.0k citations

15 papers · 539 indexed · h-index 11

Impact in

Biological Psychiatry top 10%
- Tryptophan and brain disorders
Behavioral Neuroscience top 10%
- Stress Responses and Cortisol

Papers in

Biological Psychiatry 3
- Tryptophan and brain disorders 3
Behavioral Neuroscience 2
- Stress Responses and Cortisol 2

Co-authors: Andrew J. Brown Peter S. Marshall Melanie Leveridge Gerard M.P. Giblin Brian P. Slingsby William L. Mitchell Paul Goldsmith Andrew J. Eatherton
Journals: SLAS DISCOVERY (4 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Pharmacology (1 paper)
Partner nations: United Kingdom Poland Italy

In The Last Decade

Carl Haslam

15 papers receiving 522 citations

Peers

Countries citing papers authored by Carl Haslam

Since Specialization

Citations

This map shows the geographic impact of Carl Haslam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Haslam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Haslam more than expected).

Fields of papers citing papers by Carl Haslam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Haslam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Haslam. The network helps show where Carl Haslam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carl Haslam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carl Haslam Line = papers co-authored together Carl Haslam links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Structure–activity studies of Streptococcus pyogenes enzyme SpyCEP reveal high affinity for CXCL8 in the SpyCEP C-terminal Scientific Reports ·Max Pearson, Carl Haslam, Andrew Fosberry, Emma J. Jones, Mark Reglinski, Lucy Reeves, Robert J. Edwards, Sarah Khalid Basudan, Jonathan C. Brown, Danuta E. Mossakowska, James E. Pease, Shiranee Sriskandan	2023	1
2	Reducing False Positives through the Application of Fluorescence Lifetime Technology: A Comparative Study Using TYK2 Kinase as a Model System SLAS DISCOVERY ·О Л Нифонтова, Т.Б. Попова, Richard D. Farn, სალომე წიკლაური, Konferencja Klimatologiczna na temat Współczesne Badania Topoklimatologiczne, Sam M. Rowe, Paul Rowland, Silvena Boteva, Carl Haslam, Ryan P. Bingham, Peter D. Craggs	2021	1
3	Structure-Activity Relationship of the GPR55 Antagonist, CID16020046 Pharmacology ·Andrew J. Brown, Joanne Nicholson, Carl Haslam, Satya Nandini Arjunan, Simon J. Dowell	2018	11
4	Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase Nature Communications ·Jonathan P. Hutchinson, Paul Rowland, Michiel Stock, 郭惠学, Carl Haslam, Clare I. Hobbs, Duncan S. Holmes, Paul Homes, John Liddle, Damian J. Mole, Iain Uings, Ann L. Walker, Scott P. Webster, Christopher G. Mowat, Chun‐wa Chung	2017	37
5	The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis Bioorganic & Medicinal Chemistry Letters ·John Liddle, 敦藤永, Margaret Binnie, Anne Bouillot, Alexis Denis, Michael M. Hann, Carl Haslam, Duncan S. Holmes, Lucio Manuel, Michael Kranz, Andrew McBride, Olivier Mirguet, Damian J. Mole, Christopher G. Mowat, Sandeep Pal, Paul Rowland, Lionel Trottet, Iain Uings, Ann L. Walker, Scott P. Webster	2017	9
6	A Systematic Investigation of the Best Buffers for Use in Screening by MALDI–Mass Spectrometry SLAS DISCOVERY ·Jiang-Bin Feng, Carl Haslam, Zakiye Gohari, Melanie Leveridge, Peter S. Marshall	2016	28
7	The Evolution of MALDI-TOF Mass Spectrometry toward Ultra-High-Throughput Screening: 1536-Well Format and Beyond SLAS DISCOVERY ·Carl Haslam, L. Shekhtman, Adrian J. Dunn, B.A. Kennedy, Zakiye Gohari, Peter S. Marshall, Rainer Paape, Temeka Brooks, A. Romagosa Pérez-Portabella, Melanie Leveridge	2015	104
8	Lead Discovery for Human Kynurenine 3-Monooxygenase by High-Throughput RapidFire Mass Spectrometry SLAS DISCOVERY ·Denise M. Lowe, Michelle Gee, Carl Haslam, Olena Omelchischina, 郭惠学, José Luis Sesé Mazana, Mariassunta Porcelli, Argyrides Argyrou, Scott P. Webster, Damian J. Mole, Н. І. Бігун, Margaret Binnie, Th Omas Geisen, Tony W. Dean, John Liddle, Iain Uings, Jonathan P. Hutchinson	2013	31
9	Pharmacology of GPR55 in Yeast and Identification of GSK494581A as a Mixed-Activity Glycine Transporter Subtype 1 Inhibitor and GPR55 Agonist Journal of Pharmacology and Experimental Therapeutics ·Andrew J. Brown, Dion A. Daniels, Muhammad Gufron Purnama, 郭廷良, Carl Haslam, Eiji Suwa, Jason Brown, Satya Nandini Arjunan, 裘文文, Alan Wise, Simon J. Dowell	2011	56
10	2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure–activity relationships Bioorganic & Medicinal Chemistry Letters ·Robert J. Gleave, Paul Beswick, Andrew J. Brown, Gerard M.P. Giblin, Carl Haslam, David G. Livermore, Rosalie Émond-Tremblay, Neville Nicholson, Lee W. Page, Brian P. Slingsby, Martin E. Swarbrick	2009	9
11	Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB2 agonists for the treatment of inflammatory pain Bioorganic & Medicinal Chemistry Letters ·Robert J. Gleave, Paul Beswick, Andrew J. Brown, Gerard M.P. Giblin, Paul Goldsmith, Carl Haslam, William L. Mitchell, Neville Nicholson, Lee W. Page, Sadhana Patel, Julien Gaffuri, Brian P. Slingsby, Martin E. Swarbrick	2009	34
12	Discovery of 1-[4-(3-Chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a Brain Penetrant 5-Azaindole CB₂Agonist for the Treatment of Chronic Pain Journal of Medicinal Chemistry ·Gerard M.P. Giblin, Andrew Billinton, Michael A. Briggs, Andrew J. Brown, Iain P. Chessell, Nick M. Clayton, Andrew J. Eatherton, Paul Goldsmith, Carl Haslam, Matthew R. Johnson, William L. Mitchell, Alan Naylor, Alcide Perboni, Brian P. Slingsby, Alex Wilson	2009	43
13	Pyridine-3-carboxamides as novel CB2 agonists for analgesia Bioorganic & Medicinal Chemistry Letters ·William L. Mitchell, Gerard M.P. Giblin, Alan Naylor, Andrew J. Eatherton, Brian P. Slingsby, Sabine Rodriguez-Smith, Karamjit S. Jandu, Carl Haslam, Andrew J. Brown, Paul Goldsmith, Nick M. Clayton, Alex Wilson, Iain P. Chessell, Richard H. Green, Andrew R. Whittington, Ian D. Wall	2008	20
14	Discovery of 2-[(2,4-Dichlorophenyl)amino]- N -[(tetrahydro- 2 H -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain Journal of Medicinal Chemistry ·Gerard M.P. Giblin, Celestine T. O’Shaughnessy, Alan Naylor, William L. Mitchell, Andrew J. Eatherton, Brian P. Slingsby, Xiong Ke, Paul Goldsmith, Andrew J. Brown, Carl Haslam, Nick M. Clayton, Alex Wilson, Iain P. Chessell, Guillermina Jacob, Richard Green	2007	109
15	Selectivity of d[Cha⁴]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V_1b/oxytocin receptor antagonist British Journal of Pharmacology ·Cristiana Griffante, Andrew R. Green, Ornella Curcuruto, Carl Haslam, Fran O'Neil, Roberto Arban	2005	46

About Carl Haslam

Carl Haslam is a scholar working on Biological Psychiatry, Behavioral Neuroscience, Pharmacology, Cellular and Molecular Neuroscience and Physiology, having authored 15 papers that have together received 539 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Tryptophan and brain disorders (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers), Bipolar Disorder and Treatment (3 papers), Stress Responses and Cortisol (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Biological Psychiatry (57 citations), Behavioral Neuroscience (54 citations), Pharmacology (175 citations), Cellular and Molecular Neuroscience (133 citations) and Toxicology (21 citations). Carl Haslam has collaborated with scholars based in United Kingdom, Poland and Italy. Frequent co-authors include Andrew J. Brown, Peter S. Marshall, Melanie Leveridge, Gerard M.P. Giblin, Brian P. Slingsby, William L. Mitchell, Paul Goldsmith, Andrew J. Eatherton, Iain P. Chessell and Nick M. Clayton. Their work appears in journals such as SLAS DISCOVERY, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact